Admission 0 9 0 9 O
Date 10 14 10 14 O
: 14 15 15 16 O
[ 16 17 17 18 O
* 17 18 19 20 O
* 18 19 21 22 O
2178 19 23 23 27 O
- 23 24 28 29 O
1 24 25 30 31 O
- 25 26 32 33 O
20 26 28 34 36 O
* 28 29 37 38 O
* 29 30 39 40 O
] 30 31 41 42 O
Discharge 39 48 43 52 O
Date 49 53 53 57 O
: 53 54 58 59 O
[ 55 56 60 61 O
* 56 57 62 63 O
* 57 58 64 65 O
2178 58 62 66 70 O
- 62 63 71 72 O
2 63 64 73 74 O
- 64 65 75 76 O
7 65 66 77 78 O
* 66 67 79 80 O
* 67 68 81 82 O
] 68 69 83 84 O
Date 71 75 85 89 O
of 76 78 90 92 O
Birth 79 84 93 98 O
: 84 85 99 100 O
[ 87 88 101 102 O
* 88 89 103 104 O
* 89 90 105 106 O
2107 90 94 107 111 O
- 94 95 112 113 O
2 95 96 114 115 O
- 96 97 116 117 O
15 97 99 118 120 O
* 99 100 121 122 O
* 100 101 123 124 O
] 101 102 125 126 O
Sex 110 113 127 130 O
: 113 114 131 132 O
M 116 117 133 134 O

Service 119 126 135 142 O
: 126 127 143 144 O
OME 129 132 145 148 O

HISTORY 135 142 149 156 O
OF 143 145 157 159 O
PRESENT 146 153 160 167 O
ILLNESS 154 161 168 175 O
: 161 162 176 177 O
This 164 168 178 182 O
patient 169 176 183 190 O
is 177 179 191 193 O
a 180 181 194 195 O
70 182 184 196 198 O
- 184 185 199 200 O
year 185 189 201 205 O
- 189 190 206 207 O
old 190 193 208 211 O
male 194 198 212 216 O
with 199 203 217 221 O
extensive 204 213 222 231 O
locally 214 221 232 239 O
recurrent 222 231 240 249 O
melanoma 232 240 250 258 B-Reason
involving 241 250 259 268 O
his 251 254 269 272 O
face 255 259 273 277 O
, 259 260 278 279 O
status 261 267 280 286 O
post 268 272 287 291 O
excision 273 281 292 300 O
, 281 282 301 302 O
neck 283 287 303 307 O
dissection 288 298 308 318 O
and 299 302 319 322 O
radiation 303 312 323 332 O
therapy 313 320 333 340 O
. 320 321 341 342 O

Initial 323 330 343 350 O
staging 331 338 351 358 O
was 339 342 359 362 O
consistent 343 353 363 373 O
with 354 358 374 378 O
stage 359 364 379 384 O
III 365 368 385 388 O
C 369 370 389 390 O
disease 371 378 391 398 O
but 379 382 399 402 O
now 383 386 403 406 O
with 387 391 407 411 O
mets 392 396 412 416 O
to 397 399 417 419 O
the 400 403 420 423 O
lung 404 408 424 428 O
, 408 409 429 430 O
bone 410 414 431 435 O
and 415 418 436 439 O
soft 419 423 440 444 O
tissue 424 430 445 451 O
. 430 431 452 453 O

He 432 434 454 456 O
was 435 438 457 460 O
due 439 442 461 464 O
to 443 445 465 467 O
be 446 448 468 470 O
started 449 456 471 478 O
on 457 459 479 481 O
high 460 464 482 486 B-Dosage
- 464 465 487 488 I-Dosage
dose 465 469 489 493 I-Dosage
IL 470 472 494 496 B-Drug
- 472 473 497 498 I-Drug
2 473 474 499 500 I-Drug
but 475 478 501 504 O
in 479 481 505 507 O
clinic 482 488 508 514 O
on 489 491 515 517 O
[ 492 493 518 519 O
* 493 494 520 521 O
* 494 495 522 523 O
2178 495 499 524 528 O
- 499 500 529 530 O
1 500 501 531 532 O
- 501 502 533 534 O
12 502 504 535 537 O
* 504 505 539 540 O
* 505 506 541 542 O
] 506 507 543 544 O
, 507 508 545 546 O
he 509 511 547 549 O
was 512 515 550 553 O
noticed 516 523 554 561 O
to 524 526 562 564 O
have 527 531 565 569 O
erythema 532 540 570 578 O
in 541 543 579 581 O
an 544 546 582 584 O
area 547 551 585 589 O
of 552 554 590 592 O
recent 555 561 593 599 O
lymph 562 567 600 605 O
node 568 572 606 610 O
dissection 573 583 611 621 O
felt 584 588 622 626 O
consistent 589 599 627 637 O
with 600 604 638 642 O
cellulitis 605 615 643 653 B-Reason
, 615 616 654 655 O
and 617 620 656 659 O
was 621 624 660 663 O
started 625 632 664 671 O
on 633 635 672 674 O
oral 636 640 675 679 B-Route
Keflex 641 647 680 686 B-Drug
, 647 648 687 688 O
and 649 652 689 692 O
now 653 656 693 696 O
is 657 659 697 699 O
presenting 660 670 700 710 O
with 671 675 711 715 O
worsening 676 685 716 725 O
erythema 686 694 726 734 O
. 694 695 735 736 O

The 697 700 737 740 O
patient 701 708 741 748 O
reports 709 716 749 756 O
that 717 721 757 761 O
in 722 724 762 764 O
the 725 728 765 768 O
week 729 733 769 773 O
since 734 739 774 779 O
he 740 742 780 782 O
started 743 750 783 790 O
antibiotics 751 762 791 802 B-Drug
, 762 763 803 804 O
the 764 767 805 808 O
erythema 768 776 809 817 O
has 777 780 818 821 O
enlarged 781 789 822 830 O
and 790 793 831 834 O
become 794 800 835 841 O
more 801 805 842 846 O
red 806 809 847 850 O
. 809 810 851 852 O

In 812 814 853 855 O
clinic 815 821 856 862 O
today 822 827 863 868 O
, 827 828 869 870 O
his 829 832 871 874 O
white 833 838 875 880 O
blood 839 844 881 886 O
cell 845 849 887 891 O
count 850 855 892 897 O
was 856 859 898 901 O
up 860 862 902 904 O
to 863 865 905 907 O
20 866 868 908 910 O
, 868 869 911 912 O
000 869 872 913 916 O
and 873 876 917 920 O
he 877 879 921 923 O
was 880 883 924 927 O
admitted 884 892 928 936 O
to 893 895 937 939 O
OMED 896 900 940 944 O
service 901 908 945 952 O
. 908 909 953 954 O

PAST 911 915 955 959 O
MEDICAL 916 923 960 967 O
HISTORY 924 931 968 975 O
: 931 932 976 977 O
Hypertension 934 946 978 990 O
, 946 947 991 992 O
metastatic 948 958 993 1003 O
melanoma 959 967 1004 1012 O
with 968 972 1013 1017 O
original 973 981 1018 1026 O
diagnosis 982 991 1027 1036 O
in 992 994 1037 1039 O
[ 995 996 1040 1041 O
* 996 997 1042 1043 O
* 997 998 1044 1045 O
2177 998 1002 1046 1050 O
- 1002 1003 1051 1052 O
6 1003 1004 1053 1054 O
- 1004 1005 1055 1056 O
5 1005 1006 1057 1058 O
* 1006 1007 1059 1060 O
* 1007 1008 1061 1062 O
] 1008 1009 1063 1064 O
. 1009 1010 1065 1066 O

On 1012 1014 1067 1069 O
[ 1015 1016 1070 1071 O
* 1016 1017 1072 1073 O
* 1017 1018 1074 1075 O
2177 1018 1022 1076 1080 O
- 1022 1023 1081 1082 O
8 1023 1024 1083 1084 O
- 1024 1025 1085 1086 O
21 1025 1027 1087 1089 O
* 1027 1028 1090 1091 O
* 1028 1029 1092 1093 O
] 1029 1030 1094 1095 O
he 1031 1033 1096 1098 O
underwent 1034 1043 1099 1108 O
wide 1044 1048 1109 1113 O
local 1049 1054 1114 1119 O
excision 1055 1063 1120 1128 O
and 1064 1067 1129 1132 O
sentinel 1068 1076 1133 1141 O
lymph 1077 1082 1142 1147 O
node 1083 1087 1148 1152 O
biopsy 1088 1094 1153 1159 O
, 1094 1095 1160 1161 O
with 1096 1100 1162 1166 O
melanoma 1101 1109 1167 1175 O
present 1110 1117 1176 1183 O
in 1118 1120 1184 1186 O
1 1121 1122 1187 1188 O
left 1123 1127 1189 1193 O
intraparotid 1128 1140 1194 1206 O
node 1141 1145 1207 1211 O
. 1145 1146 1212 1213 O

On 1148 1150 1214 1216 O
[ 1151 1152 1217 1218 O
* 1152 1153 1219 1220 O
* 1153 1154 1221 1222 O
2177 1154 1158 1223 1227 O
- 1158 1159 1228 1229 O
8 1159 1160 1230 1231 O
- 1160 1161 1232 1233 O
28 1161 1163 1234 1236 O
* 1163 1164 1237 1238 O
* 1164 1165 1239 1240 O
] 1165 1166 1241 1242 O
he 1167 1169 1243 1245 O
had 1170 1173 1246 1249 O
re 1174 1176 1250 1252 O
- 1176 1177 1253 1254 O
excision 1177 1185 1255 1263 O
of 1186 1188 1264 1266 O
the 1189 1192 1267 1270 O
left 1193 1197 1271 1275 O
temple 1198 1204 1276 1282 O
and 1205 1208 1283 1286 O
cheek 1209 1214 1287 1292 O
area 1215 1219 1293 1297 O
and 1220 1223 1298 1301 O
a 1224 1225 1302 1303 O
left 1226 1230 1304 1308 O
radical 1231 1238 1309 1316 O
neck 1239 1243 1317 1321 O
dissection 1244 1254 1322 1332 O
, 1254 1255 1333 1334 O
with 1256 1260 1335 1339 O
melanoma 1261 1269 1340 1348 O
in 1270 1272 1349 1351 O
7 1273 1274 1352 1353 O
of 1275 1277 1354 1356 O
69 1278 1280 1357 1359 O
total 1281 1286 1360 1365 O
lymph 1287 1292 1366 1371 O
nodes 1293 1298 1372 1377 O
. 1298 1299 1378 1379 O

He 1301 1303 1380 1382 O
underwent 1304 1313 1383 1392 O
radiation 1314 1323 1393 1402 O
therapy 1324 1331 1403 1410 O
to 1332 1334 1411 1413 O
the 1335 1338 1414 1417 O
forehead 1339 1347 1418 1426 O
area 1348 1352 1427 1431 O
, 1352 1353 1432 1433 O
completing 1354 1364 1434 1444 O
20 1365 1367 1445 1447 O
fractions 1368 1377 1448 1457 O
over 1378 1382 1458 1462 O
4 1383 1384 1463 1464 O
weeks 1385 1390 1465 1470 O
. 1390 1391 1471 1472 O

He 1393 1395 1473 1475 O
then 1396 1400 1476 1480 O
developed 1401 1410 1481 1490 O
soft 1411 1415 1491 1495 O
tissue 1416 1422 1496 1502 O
nodule 1423 1429 1503 1509 O
superior 1430 1438 1510 1518 O
to 1439 1441 1519 1521 O
the 1442 1445 1522 1525 O
graft 1446 1451 1526 1531 O
, 1451 1452 1532 1533 O
that 1453 1457 1534 1538 O
might 1458 1463 1539 1544 O
have 1464 1468 1545 1549 O
represented 1469 1480 1550 1561 O
residual 1481 1489 1562 1570 O
melanoma 1490 1498 1571 1579 O
and 1499 1502 1580 1583 O
appeared 1503 1511 1584 1592 O
to 1512 1514 1593 1595 O
have 1515 1519 1596 1600 O
reduced 1520 1527 1601 1608 O
in 1528 1530 1609 1611 O
size 1531 1535 1612 1616 O
with 1536 1540 1617 1621 O
radiation 1541 1550 1622 1631 O
. 1550 1551 1632 1633 O

In 1553 1555 1634 1636 O
late 1556 1560 1637 1641 O
[ 1561 1562 1642 1643 O
* 1562 1563 1644 1645 O
* 1563 1564 1646 1647 O
2177 1564 1568 1648 1652 O
- 1568 1569 1653 1654 O
10 1569 1571 1655 1657 O
- 1571 1572 1658 1659 O
6 1572 1573 1660 1661 O
* 1573 1574 1662 1663 O
* 1574 1575 1664 1665 O
] 1575 1576 1666 1667 O
a 1577 1578 1668 1669 O
PET 1579 1582 1670 1673 O
CT 1583 1585 1674 1676 O
showed 1586 1592 1677 1683 O
increased 1593 1602 1684 1693 O
glucose 1603 1610 1694 1701 O
uptake 1611 1617 1702 1708 O
at 1618 1620 1709 1711 O
sites 1621 1626 1712 1717 O
of 1627 1629 1718 1720 O
surgery 1630 1637 1721 1728 O
on 1638 1640 1729 1731 O
his 1641 1644 1732 1735 O
thigh 1645 1650 1736 1741 O
and 1651 1654 1742 1745 O
around 1655 1661 1746 1752 O
the 1662 1665 1753 1756 O
superior 1666 1674 1757 1765 O
edge 1675 1679 1766 1770 O
of 1680 1682 1771 1773 O
the 1683 1686 1774 1777 O
graft 1687 1692 1778 1783 O
on 1693 1695 1784 1786 O
his 1696 1699 1787 1790 O
face 1700 1704 1791 1795 O
. 1704 1705 1796 1797 O

He 1707 1709 1798 1800 O
was 1710 1713 1801 1804 O
seen 1714 1718 1805 1809 O
in 1719 1721 1810 1812 O
follow 1722 1728 1813 1819 O
- 1728 1729 1820 1821 O
up 1729 1731 1822 1824 O
one 1732 1735 1825 1828 O
of 1736 1738 1829 1831 O
three 1739 1744 1832 1837 O
weeks 1745 1750 1838 1843 O
after 1751 1756 1844 1849 O
completion 1757 1767 1850 1860 O
of 1768 1770 1861 1863 O
radiation 1771 1780 1864 1873 O
. 1780 1781 1874 1875 O

Follow 1782 1788 1876 1882 O
up 1789 1791 1883 1885 O
head 1792 1796 1886 1890 O
MRI 1797 1800 1891 1894 O
and 1801 1804 1895 1898 O
torso 1805 1810 1899 1904 O
CT 1811 1813 1905 1907 O
on 1814 1816 1908 1910 O
[ 1817 1818 1911 1912 O
* 1818 1819 1913 1914 O
* 1819 1820 1915 1916 O
2178 1820 1824 1917 1921 O
- 1824 1825 1922 1923 O
1 1825 1826 1924 1925 O
- 1826 1827 1926 1927 O
7 1827 1828 1928 1929 O
* 1828 1829 1930 1931 O
* 1829 1830 1932 1933 O
] 1830 1831 1934 1935 O
revealed 1832 1840 1936 1944 O
no 1841 1843 1945 1947 O
metastatic 1844 1854 1948 1958 O
brain 1855 1860 1959 1964 O
lesions 1861 1868 1965 1972 O
, 1868 1869 1973 1974 O
but 1870 1873 1975 1978 O
metastatic 1874 1884 1979 1989 O
disease 1885 1892 1990 1997 O
in 1893 1895 1998 2000 O
his 1896 1899 2001 2004 O
chest 1900 1905 2005 2010 O
, 1905 1906 2011 2012 O
left 1907 1911 2013 2017 O
axilla 1912 1918 2018 2024 O
, 1918 1919 2025 2026 O
mediastinum 1920 1931 2027 2038 O
and 1932 1935 2039 2042 O
lung 1936 1940 2043 2047 O
, 1940 1941 2048 2049 O
as 1942 1944 2050 2052 O
well 1945 1949 2053 2057 O
as 1950 1952 2058 2060 O
a 1953 1954 2061 2062 O
T12 1955 1958 2063 2066 O
sclerotic 1959 1968 2067 2076 O
focus 1969 1974 2077 2082 O
felt 1975 1979 2083 2087 O
consistent 1980 1990 2088 2098 O
with 1991 1995 2099 2103 O
melanoma 1996 2004 2104 2112 B-Reason
. 2004 2005 2113 2114 O

The 2007 2010 2115 2118 O
BRCA 2011 2015 2119 2123 O
mutation 2016 2024 2124 2132 O
testing 2025 2032 2133 2140 O
on 2033 2035 2141 2143 O
his 2036 2039 2144 2147 O
tumor 2040 2045 2148 2153 O
was 2046 2049 2154 2157 O
negative 2050 2058 2158 2166 O
. 2058 2059 2167 2168 O

He 2061 2063 2169 2171 O
has 2064 2067 2172 2175 O
passed 2068 2074 2176 2182 O
screening 2075 2084 2183 2192 O
tests 2085 2090 2193 2198 O
to 2091 2093 2199 2201 O
begin 2094 2099 2202 2207 O
high 2100 2104 2208 2212 B-Dosage
- 2104 2105 2213 2214 I-Dosage
dose 2105 2109 2215 2219 I-Dosage
IL 2110 2112 2220 2222 B-Drug
- 2112 2113 2223 2224 I-Drug
2 2113 2114 2225 2226 I-Drug
therapy 2115 2122 2227 2234 O
. 2122 2123 2235 2236 O

ALLERGIES 2125 2134 2237 2246 O
: 2134 2135 2247 2248 O
No 2137 2139 2249 2251 O
known 2140 2145 2252 2257 O
drug 2146 2150 2258 2262 O
allergies 2151 2160 2263 2272 O
. 2160 2161 2273 2274 O

MEDICATIONS 2163 2174 2275 2286 O
ON 2175 2177 2287 2289 O
ADMISSION 2178 2187 2290 2299 O
: 2187 2188 2300 2301 O
Enalapril 2190 2199 2302 2311 B-Drug
20 2200 2202 2312 2314 B-Strength
mg 2203 2205 2315 2317 I-Strength
p.o. 2206 2210 2318 2322 B-Route
daily 2211 2216 2323 2328 B-Frequency
, 2216 2217 2329 2330 O
pravastatin 2218 2229 2331 2342 B-Drug
20 2230 2232 2343 2345 B-Strength
mg 2233 2235 2346 2348 I-Strength
p.o. 2236 2240 2349 2353 B-Route
daily 2241 2246 2354 2359 B-Frequency
, 2246 2247 2360 2361 O
Keflex 2248 2254 2362 2368 B-Drug
500 2255 2258 2369 2372 B-Strength
mg 2259 2261 2373 2375 I-Strength
p.o. 2262 2266 2376 2380 B-Route
b.i.d. 2267 2273 2381 2387 B-Frequency

PHYSICAL 2275 2283 2388 2396 O
EXAMINATION 2284 2295 2397 2408 O
ON 2296 2298 2409 2411 O
ADMISSION 2299 2308 2412 2421 O
: 2308 2309 2422 2423 O
Reveals 2311 2318 2424 2431 O
an 2319 2321 2432 2434 O
elderly 2322 2329 2435 2442 O
male 2330 2334 2443 2447 O
in 2335 2337 2448 2450 O
no 2338 2340 2451 2453 O
apparent 2341 2349 2454 2462 O
distress 2350 2358 2463 2471 O
. 2358 2359 2472 2473 O

HEENT 2361 2366 2474 2479 O
: 2366 2367 2480 2481 O
Pupils 2369 2375 2482 2488 O
equal 2376 2381 2489 2494 O
, 2381 2382 2495 2496 O
round 2383 2388 2497 2502 O
, 2388 2389 2503 2504 O
reactive 2390 2398 2505 2513 O
to 2399 2401 2514 2516 O
light 2402 2407 2517 2522 O
. 2407 2408 2523 2524 O

Left 2410 2414 2525 2529 O
temporal 2415 2423 2530 2538 O
and 2424 2427 2539 2542 O
buccal 2428 2434 2543 2549 O
graft 2435 2440 2550 2555 O
without 2441 2448 2556 2563 O
erythema 2449 2457 2564 2572 O
. 2457 2458 2573 2574 O

NECK 2460 2464 2575 2579 O
: 2464 2465 2580 2581 O
Well 2467 2471 2582 2586 O
- 2471 2472 2587 2588 O
healed 2472 2478 2589 2595 O
scar 2479 2483 2596 2600 O
from 2484 2488 2601 2605 O
posterior 2489 2498 2606 2615 O
auricular 2499 2508 2616 2625 O
area 2509 2513 2626 2630 O
to 2514 2516 2631 2633 O
the 2517 2520 2634 2637 O
left 2521 2525 2638 2642 O
upper 2526 2531 2643 2648 O
chest 2532 2537 2649 2654 O
. 2537 2538 2655 2656 O

No 2540 2542 2657 2659 O
signs 2543 2548 2660 2665 O
of 2549 2551 2666 2668 O
wound 2552 2557 2669 2674 O
dehiscence 2558 2568 2675 2685 O
. 2568 2569 2686 2687 O

Broad 2570 2575 2688 2693 O
area 2576 2580 2694 2698 O
of 2581 2583 2699 2701 O
erythema 2584 2592 2702 2710 O
and 2593 2596 2711 2714 O
corresponding 2597 2610 2715 2728 O
area 2611 2615 2729 2733 O
warm 2616 2620 2734 2738 O
to 2621 2623 2739 2741 O
touch 2624 2629 2742 2747 O
. 2629 2630 2748 2749 O

No 2631 2633 2750 2752 O
palpable 2634 2642 2753 2761 O
masses 2643 2649 2762 2768 O
or 2650 2652 2769 2771 O
fluid 2653 2658 2772 2777 O
collections 2659 2670 2778 2789 O
. 2670 2671 2790 2791 O

No 2673 2675 2792 2794 O
cervical 2676 2684 2795 2803 O
, 2684 2685 2804 2805 O
supraclavicular 2686 2701 2806 2821 O
or 2702 2704 2822 2824 O
axillary 2705 2713 2825 2833 O
lymphadenopathy 2714 2729 2834 2849 O
. 2729 2730 2850 2851 O

HEART 2732 2737 2852 2857 O
: 2737 2738 2858 2859 O
Regular 2740 2747 2860 2867 O
rate 2748 2752 2868 2872 O
and 2753 2756 2873 2876 O
rhythm 2757 2763 2877 2883 O
, 2763 2764 2884 2885 O
S1 2765 2767 2886 2888 O
, 2767 2768 2889 2890 O
S2. 2769 2772 2891 2894 O
CHEST 2774 2779 2895 2900 O
: 2779 2780 2901 2902 O
No 2782 2784 2903 2905 O
dullness 2785 2793 2906 2914 O
to 2794 2796 2915 2917 O
percussion 2797 2807 2918 2928 O
and 2808 2811 2929 2932 O
clear 2812 2817 2933 2938 O
to 2818 2820 2939 2941 O
auscultation 2821 2833 2942 2954 O
bilaterally 2834 2845 2955 2966 O
. 2845 2846 2967 2968 O

ABDOMEN 2848 2855 2969 2976 O
: 2855 2856 2977 2978 O
Positive 2858 2866 2979 2987 O
bowel 2867 2872 2988 2993 O
sounds 2873 2879 2994 3000 O
, 2879 2880 3001 3002 O
soft 2881 2885 3003 3007 O
, 2885 2886 3008 3009 O
nontender 2887 2896 3010 3019 O
. 2896 2897 3020 3021 O

EXTREMITIES 2899 2910 3022 3033 O
: 2910 2911 3034 3035 O
Warm 2913 2917 3036 3040 O
and 2918 2921 3041 3044 O
well 2922 2926 3045 3049 O
perfused 2927 2935 3050 3058 O
, 2935 2936 3059 3060 O
1 2937 2938 3061 3062 O
+ 2938 2939 3063 3064 O
edema 2940 2945 3065 3070 O
to 2946 2948 3071 3073 O
[ 2949 2950 3074 3075 O
* 2950 2951 3076 3077 O
* 2951 2952 3078 3079 O
12 2952 2954 3080 3082 O
- 2954 2955 3084 3085 O
8 2955 2956 3086 3087 O
* 2956 2957 3088 3089 O
* 2957 2958 3090 3091 O
] 2958 2959 3092 3093 O
the 2960 2963 3094 3097 O
way 2964 2967 3098 3101 O
up 2968 2970 3102 3104 O
shins 2971 2976 3105 3110 O
bilaterally 2977 2988 3111 3122 O
, 2988 2989 3123 3124 O
2 2990 2991 3125 3126 O
+ 2991 2992 3127 3128 O
DP 2993 2995 3129 3131 O
and 2996 2999 3132 3135 O
PT 3000 3002 3136 3138 O
pulses 3003 3009 3139 3145 O
. 3009 3010 3146 3147 O

NEUROLOGIC 3012 3022 3148 3158 O
EXAM 3023 3027 3159 3163 O
: 3027 3028 3164 3165 O
Nonfocal 3030 3038 3166 3174 O
. 3038 3039 3175 3176 O

ADMISSION 3041 3050 3177 3186 O
LABS 3051 3055 3187 3191 O
: 3055 3056 3192 3193 O
WBC 3058 3061 3194 3197 O
20.9 3062 3066 3198 3202 O
, 3066 3067 3203 3204 O
hemoglobin 3068 3078 3205 3215 O
11.7 3079 3083 3216 3220 O
, 3083 3084 3221 3222 O
hematocrit 3085 3095 3223 3233 O
33.7 3096 3100 3234 3238 O
, 3100 3101 3239 3240 O
platelet 3102 3110 3241 3249 O
count 3111 3116 3250 3255 O
206 3117 3120 3256 3259 O
, 3120 3121 3260 3261 O
000 3121 3124 3262 3265 O
, 3124 3125 3266 3267 O
BUN 3126 3129 3268 3271 O
20 3130 3132 3272 3274 O
, 3132 3133 3275 3276 O
creatinine 3134 3144 3277 3287 O
1.2 3145 3148 3288 3291 O
, 3148 3149 3292 3293 O
sodium 3150 3156 3294 3300 O
134 3157 3160 3301 3304 O
, 3160 3161 3305 3306 O
potassium 3162 3171 3307 3316 O
6.1 3172 3175 3317 3320 O
, 3175 3176 3321 3322 O
chloride 3177 3185 3323 3331 O
101 3186 3189 3332 3335 O
, 3189 3190 3336 3337 O
CO 3191 3193 3338 3340 O
2 3193 3194 3341 3342 O
23 3195 3197 3343 3345 O
, 3197 3198 3346 3347 O
glucose 3199 3206 3348 3355 O
117 3207 3210 3356 3359 O
. 3210 3211 3360 3361 O

HOSPITAL 3213 3221 3362 3370 O
COURSE 3222 3228 3371 3377 O
: 3228 3229 3378 3379 O
The 3231 3234 3380 3383 O
patient 3235 3242 3384 3391 O
was 3243 3246 3392 3395 O
admitted 3247 3255 3396 3404 O
with 3256 3260 3405 3409 O
cellulitis 3261 3271 3410 3420 B-Reason
and 3272 3275 3421 3424 O
was 3276 3279 3425 3428 O
placed 3280 3286 3429 3435 O
on 3287 3289 3436 3438 O
IV 3290 3292 3439 3441 B-Route
vancomycin 3293 3303 3442 3452 B-Drug
. 3303 3304 3453 3454 O

Doxycycline 3306 3317 3455 3466 B-Drug
was 3318 3321 3467 3470 O
added 3322 3327 3471 3476 O
when 3328 3332 3477 3481 O
he 3333 3335 3482 3484 O
did 3336 3339 3485 3488 O
not 3340 3343 3489 3492 O
appear 3344 3350 3493 3499 O
to 3351 3353 3500 3502 O
be 3354 3356 3503 3505 O
improving 3357 3366 3506 3515 O
. 3366 3367 3516 3517 O

Unasyn 3369 3375 3518 3524 B-Drug
was 3376 3379 3525 3528 O
added 3380 3385 3529 3534 O
when 3386 3390 3535 3539 O
the 3391 3394 3540 3543 O
cellulitic 3395 3405 3544 3554 B-Reason
area 3406 3410 3555 3559 I-Reason
continued 3411 3420 3560 3569 I-Reason
to 3421 3423 3570 3572 I-Reason
worsen 3424 3430 3573 3579 I-Reason
. 3430 3431 3580 3581 O

He 3433 3435 3582 3584 O
also 3436 3440 3585 3589 O
became 3441 3447 3590 3596 O
short 3448 3453 3597 3602 B-Reason
of 3454 3456 3603 3605 I-Reason
breath 3457 3463 3606 3612 I-Reason
and 3464 3467 3613 3616 O
was 3468 3471 3617 3620 O
treated 3472 3479 3621 3628 O
with 3480 3484 3629 3633 O
Lasix 3485 3490 3634 3639 B-Drug
. 3490 3491 3640 3641 O

Transthoracic 3493 3506 3642 3655 O
echo 3507 3511 3656 3660 O
revealed 3512 3520 3661 3669 O
diastolic 3521 3530 3670 3679 B-Reason
heart 3531 3536 3680 3685 I-Reason
failure 3537 3544 3686 3693 I-Reason
and 3545 3548 3694 3697 O
he 3549 3551 3698 3700 O
was 3552 3555 3701 3704 O
continued 3556 3565 3705 3714 O
on 3566 3568 3715 3717 O
enalapril 3569 3578 3718 3727 B-Drug
and 3579 3582 3728 3731 O
Lasix 3583 3588 3732 3737 B-Drug
. 3588 3589 3738 3739 O

He 3591 3593 3740 3742 O
had 3594 3597 3743 3746 O
an 3598 3600 3747 3749 O
ID 3601 3603 3750 3752 O
consult 3604 3611 3753 3760 O
on 3612 3614 3761 3763 O
[ 3615 3616 3764 3765 O
* 3616 3617 3766 3767 O
* 3617 3618 3768 3769 O
1 3618 3619 3770 3771 O
- 3619 3620 3772 3773 O
28 3620 3622 3774 3776 O
* 3622 3623 3777 3778 O
* 3623 3624 3779 3780 O
] 3624 3625 3781 3782 O
who 3626 3629 3783 3786 O
suggested 3630 3639 3787 3796 O
stopping 3640 3648 3797 3805 O
the 3649 3652 3806 3809 O
Unasyn 3653 3659 3810 3816 B-Drug
, 3659 3660 3817 3818 O
changing 3661 3669 3819 3827 O
to 3670 3672 3828 3830 O
cefepime 3673 3681 3831 3839 B-Drug
and 3682 3685 3840 3843 O
adding 3686 3692 3844 3850 O
vancomycin 3693 3703 3851 3861 B-Drug
back 3704 3708 3862 3866 O
. 3708 3709 3867 3868 O

Blood 3711 3716 3869 3874 O
cultures 3717 3725 3875 3883 O
remained 3726 3734 3884 3892 O
negative 3735 3743 3893 3901 O
and 3744 3747 3902 3905 O
he 3748 3750 3906 3908 O
was 3751 3754 3909 3912 O
afebrile 3755 3763 3913 3921 O
throughout 3764 3774 3922 3932 O
this 3775 3779 3933 3937 O
time 3780 3784 3938 3942 O
. 3784 3785 3943 3944 O

Derm 3787 3791 3945 3949 O
consult 3792 3799 3950 3957 O
on 3800 3802 3958 3960 O
[ 3803 3804 3961 3962 O
* 3804 3805 3963 3964 O
* 3805 3806 3965 3966 O
1 3806 3807 3967 3968 O
- 3807 3808 3969 3970 O
28 3808 3810 3971 3973 O
* 3810 3811 3974 3975 O
* 3811 3812 3976 3977 O
] 3812 3813 3978 3979 O
was 3814 3817 3980 3983 O
obtained 3818 3826 3984 3992 O
due 3827 3830 3993 3996 O
to 3831 3833 3997 3999 O
persistent 3834 3844 4000 4010 O
rash 3845 3849 4011 4015 O
, 3849 3850 4016 4017 O
and 3851 3854 4018 4021 O
a 3855 3856 4022 4023 O
biopsy 3857 3863 4024 4030 O
was 3864 3867 4031 4034 O
performed 3868 3877 4035 4044 O
consistent 3878 3888 4045 4055 O
with 3889 3893 4056 4060 O
melanoma 3894 3902 4061 4069 B-Reason
. 3902 3903 4070 4071 O

He 3905 3907 4072 4074 O
was 3908 3911 4075 4078 O
subsequently 3912 3924 4079 4091 O
transferred 3925 3936 4092 4103 O
to 3937 3939 4104 4106 O
the 3940 3943 4107 4110 O
biologic 3944 3952 4111 4119 O
service 3953 3960 4120 4127 O
on 3961 3963 4128 4130 O
[ 3964 3965 4131 4132 O
* 3965 3966 4133 4134 O
* 3966 3967 4135 4136 O
2178 3967 3971 4137 4141 O
- 3971 3972 4142 4143 O
1 3972 3973 4144 4145 O
- 3973 3974 4146 4147 O
30 3974 3976 4148 4150 O
* 3976 3977 4151 4152 O
* 3977 3978 4153 4154 O
] 3978 3979 4155 4156 O
to 3980 3982 4157 4159 O
begin 3983 3988 4160 4165 O
high 3989 3993 4166 4170 B-Dosage
- 3993 3994 4171 4172 I-Dosage
dose 3994 3998 4173 4177 I-Dosage
IL 3999 4001 4178 4180 B-Drug
- 4001 4002 4181 4182 I-Drug
2 4002 4003 4183 4184 I-Drug
therapy 4004 4011 4185 4192 O
. 4011 4012 4193 4194 O

During 4014 4020 4195 4201 O
this 4021 4025 4202 4206 O
week 4026 4030 4207 4211 O
he 4031 4033 4212 4214 O
received 4034 4042 4215 4223 O
7 4043 4044 4224 4225 O
of 4045 4047 4226 4228 O
14 4048 4050 4229 4231 O
doses 4051 4056 4232 4237 O
with 4057 4061 4238 4242 O
7 4062 4063 4243 4244 O
doses 4064 4069 4245 4250 O
held 4070 4074 4251 4255 O
related 4075 4082 4256 4263 O
to 4083 4085 4264 4266 O
tachycardia 4086 4097 4267 4278 B-ADE
and 4098 4101 4279 4282 O
pulmonary 4102 4111 4283 4292 B-Reason
edema 4112 4117 4293 4298 I-Reason
. 4117 4118 4299 4300 O

On 4120 4122 4301 4303 O
treatment 4123 4132 4304 4313 O
day 4133 4136 4314 4317 O
# 4137 4138 4318 4319 O
4 4138 4139 4320 4321 O
, 4139 4140 4322 4323 O
he 4141 4143 4324 4326 O
was 4144 4147 4327 4330 O
tachypneic 4148 4158 4331 4341 O
with 4159 4163 4342 4346 O
hypoxia 4164 4171 4347 4354 O
to 4172 4174 4355 4357 O
the 4175 4178 4358 4361 O
mid 4179 4182 4362 4365 O
80s 4183 4186 4366 4369 O
. 4186 4187 4370 4371 O

Chest 4189 4194 4372 4377 O
x 4195 4196 4378 4379 O
- 4196 4197 4380 4381 O
ray 4198 4201 4382 4385 O
was 4202 4205 4386 4389 O
consistent 4206 4216 4390 4400 O
with 4217 4221 4401 4405 O
bilateral 4222 4231 4406 4415 B-Reason
pleural 4232 4239 4416 4423 I-Reason
effusions 4240 4249 4424 4433 I-Reason
. 4249 4250 4434 4435 O

Throughout 4251 4261 4436 4446 O
the 4262 4265 4447 4450 O
day 4266 4269 4451 4454 O
he 4270 4272 4455 4457 O
became 4273 4279 4458 4464 O
increasingly 4280 4292 4465 4477 O
more 4293 4297 4478 4482 O
tachypneic 4298 4308 4483 4493 B-Reason
and 4309 4312 4494 4497 O
fatigued 4313 4321 4498 4506 B-Reason
, 4321 4322 4507 4508 O
and 4323 4326 4509 4512 O
was 4327 4330 4513 4516 O
transferred 4331 4342 4517 4528 O
to 4343 4345 4529 4531 O
the 4346 4349 4532 4535 O
ICU 4350 4353 4536 4539 O
. 4353 4354 4540 4541 O

He 4356 4358 4542 4544 O
was 4359 4362 4545 4548 O
treated 4363 4370 4549 4556 O
with 4371 4375 4557 4561 O
Lasix 4376 4381 4562 4567 B-Drug
with 4382 4386 4568 4572 O
improvement 4387 4398 4573 4584 O
in 4399 4401 4585 4587 O
his 4402 4405 4588 4591 O
respiratory 4406 4417 4592 4603 O
status 4418 4424 4604 4610 O
. 4424 4425 4611 4612 O

An 4427 4429 4613 4615 O
echocardiogram 4430 4444 4616 4630 O
on 4445 4447 4631 4633 O
[ 4448 4449 4634 4635 O
* 4449 4450 4636 4637 O
* 4450 4451 4638 4639 O
2178 4451 4455 4640 4644 O
- 4455 4456 4645 4646 O
2 4456 4457 4647 4648 O
- 4457 4458 4649 4650 O
3 4458 4459 4651 4652 O
* 4459 4460 4653 4654 O
* 4460 4461 4655 4656 O
] 4461 4462 4657 4658 O
showed 4463 4469 4659 4665 O
a 4470 4471 4666 4667 O
small 4472 4477 4668 4673 O
pericardial 4478 4489 4674 4685 O
effusion 4490 4498 4686 4694 O
with 4499 4503 4695 4699 O
question 4504 4512 4700 4708 O
tamponade 4513 4522 4709 4718 O
physiology 4523 4533 4719 4729 O
. 4533 4534 4730 4731 O

Cardiology 4536 4546 4732 4742 O
was 4547 4550 4743 4746 O
consulted 4551 4560 4747 4756 O
and 4561 4564 4757 4760 O
felt 4565 4569 4761 4765 O
they 4570 4574 4766 4770 O
were 4575 4579 4771 4775 O
not 4580 4583 4776 4779 O
able 4584 4588 4780 4784 O
to 4589 4591 4785 4787 O
tap 4592 4595 4788 4791 O
the 4596 4599 4792 4795 O
effusion 4600 4608 4796 4804 O
. 4608 4609 4805 4806 O

He 4610 4612 4807 4809 O
underwent 4613 4622 4810 4819 O
a 4623 4624 4820 4821 O
cardiac 4625 4632 4822 4829 O
MRI 4633 4636 4830 4833 O
on 4637 4639 4834 4836 O
[ 4640 4641 4837 4838 O
* 4641 4642 4839 4840 O
* 4642 4643 4841 4842 O
2178 4643 4647 4843 4847 O
- 4647 4648 4848 4849 O
2 4648 4649 4850 4851 O
- 4649 4650 4852 4853 O
4 4650 4651 4854 4855 O
* 4651 4652 4856 4857 O
* 4652 4653 4858 4859 O
] 4653 4654 4860 4861 O
revealing 4655 4664 4862 4871 O
no 4665 4667 4872 4874 O
cardiac 4668 4675 4875 4882 O
metastases 4676 4686 4883 4893 O
and 4687 4690 4894 4897 O
no 4691 4693 4898 4900 O
tamponade 4694 4703 4901 4910 O
physiology 4704 4714 4911 4921 O
. 4714 4715 4922 4923 O

He 4717 4719 4924 4926 O
developed 4720 4729 4927 4936 O
SVT 4730 4733 4937 4940 B-Reason
to 4734 4736 4941 4943 O
the 4737 4740 4944 4947 O
140 4741 4744 4948 4951 O
s 4744 4745 4952 4953 O
on 4746 4748 4954 4956 O
[ 4749 4750 4957 4958 O
* 4750 4751 4959 4960 O
* 4751 4752 4961 4962 O
2178 4752 4756 4963 4967 O
- 4756 4757 4968 4969 O
2 4757 4758 4970 4971 O
- 4758 4759 4972 4973 O
4 4759 4760 4974 4975 O
* 4760 4761 4976 4977 O
* 4761 4762 4978 4979 O
] 4762 4763 4980 4981 O
, 4763 4764 4982 4983 O
which 4765 4770 4984 4989 O
spontaneously 4771 4784 4990 5003 O
improved 4785 4793 5004 5012 O
with 4794 4798 5013 5017 O
a 4799 4800 5018 5019 O
fluid 4801 4806 5020 5025 B-Drug
bolus 4807 4812 5026 5031 B-Dosage
. 4812 4813 5032 5033 O

His 4815 4818 5034 5037 O
respiratory 4819 4830 5038 5049 O
status 4831 4837 5050 5056 O
improved 4838 4846 5057 5065 O
with 4847 4851 5066 5070 O
continued 4852 4861 5071 5080 O
diuresis 4862 4870 5081 5089 B-Reason
, 4870 4871 5090 5091 O
and 4872 4875 5092 5095 O
he 4876 4878 5096 5098 O
was 4879 4882 5099 5102 O
transferred 4883 4894 5103 5114 O
back 4895 4899 5115 5119 O
to 4900 4902 5120 5122 O
the 4903 4906 5123 5126 O
floor 4907 4912 5127 5132 O
on 4913 4915 5133 5135 O
[ 4916 4917 5136 5137 O
* 4917 4918 5138 5139 O
* 4918 4919 5140 5141 O
2178 4919 4923 5142 5146 O
- 4923 4924 5147 5148 O
2 4924 4925 5149 5150 O
- 4925 4926 5151 5152 O
5 4926 4927 5153 5154 O
* 4927 4928 5155 5156 O
* 4928 4929 5157 5158 O
] 4929 4930 5159 5160 O
. 4930 4931 5161 5162 O

Lasix 4933 4938 5163 5168 B-Drug
and 4939 4942 5169 5172 O
enalapril 4943 4952 5173 5182 B-Drug
were 4953 4957 5183 5187 O
continued 4958 4967 5188 5197 O
and 4968 4971 5198 5201 O
he 4972 4974 5202 5204 O
was 4975 4978 5205 5208 O
weaned 4979 4985 5209 5215 O
to 4986 4988 5216 5218 O
room 4989 4993 5219 5223 O
air 4994 4997 5224 5227 O
with 4998 5002 5228 5232 O
O2 5003 5005 5233 5235 O
saturations 5006 5017 5236 5247 O
in 5018 5020 5248 5250 O
the 5021 5024 5251 5254 O
mid 5025 5028 5255 5258 O
90s 5029 5032 5259 5262 O
. 5032 5033 5263 5264 O

Physical 5035 5043 5265 5273 O
therapy 5044 5051 5274 5281 O
consult 5052 5059 5282 5289 O
was 5060 5063 5290 5293 O
initiated 5064 5073 5294 5303 O
and 5074 5077 5304 5307 O
he 5078 5080 5308 5310 O
was 5081 5084 5311 5314 O
ambulating 5085 5095 5315 5325 O
short 5096 5101 5326 5331 O
distances 5102 5111 5332 5341 O
with 5112 5116 5342 5346 O
a 5117 5118 5347 5348 O
steady 5119 5125 5349 5355 O
gait 5126 5130 5356 5360 O
. 5130 5131 5361 5362 O

He 5133 5135 5363 5365 O
was 5136 5139 5366 5369 O
discharged 5140 5150 5370 5380 O
to 5151 5153 5381 5383 O
home 5154 5158 5384 5388 O
on 5159 5161 5389 5391 O
[ 5162 5163 5392 5393 O
* 5163 5164 5394 5395 O
* 5164 5165 5396 5397 O
2178 5165 5169 5398 5402 O
- 5169 5170 5403 5404 O
2 5170 5171 5405 5406 O
- 5171 5172 5407 5408 O
7 5172 5173 5409 5410 O
* 5173 5174 5411 5412 O
* 5174 5175 5413 5414 O
] 5175 5176 5415 5416 O
with 5177 5181 5417 5421 O
a 5182 5183 5422 5423 O
plan 5184 5188 5424 5428 O
to 5189 5191 5429 5431 O
follow 5192 5198 5432 5438 O
up 5199 5201 5439 5441 O
in 5202 5204 5442 5444 O
clinic 5205 5211 5445 5451 O
on 5212 5214 5452 5454 O
[ 5215 5216 5455 5456 O
* 5216 5217 5457 5458 O
* 5217 5218 5459 5460 O
2178 5218 5222 5461 5465 O
- 5222 5223 5466 5467 O
2 5223 5224 5468 5469 O
- 5224 5225 5470 5471 O
10 5225 5227 5472 5474 O
* 5227 5228 5475 5476 O
* 5228 5229 5477 5478 O
] 5229 5230 5479 5480 O
. 5230 5231 5481 5482 O

Other 5233 5238 5483 5488 O
side 5239 5243 5489 5493 O
effects 5244 5251 5494 5501 O
related 5252 5259 5502 5509 O
to 5260 5262 5510 5512 O
IL 5263 5265 5513 5515 B-Drug
- 5265 5266 5516 5517 I-Drug
2 5266 5267 5518 5519 I-Drug
included 5268 5276 5520 5528 O
rigors 5277 5283 5529 5535 B-Reason
improved 5284 5292 5536 5544 O
with 5293 5297 5545 5549 O
Demerol 5298 5305 5550 5557 B-Drug
; 5305 5306 5558 5559 O
fatigue 5307 5314 5560 5567 B-ADE
; 5314 5315 5568 5569 O
and 5316 5319 5570 5573 O
hypotension 5320 5331 5574 5585 B-Reason
on 5332 5334 5586 5588 O
treatment 5335 5344 5589 5598 O
day 5345 5348 5599 5602 O
3 5349 5350 5603 5604 O
, 5350 5351 5605 5606 O
requiring 5352 5361 5607 5616 O
fluid 5362 5367 5617 5622 B-Drug
boluses 5368 5375 5623 5630 B-Form
. 5375 5376 5631 5632 O

During 5378 5384 5633 5639 O
this 5385 5389 5640 5644 O
week 5390 5394 5645 5649 O
he 5395 5397 5650 5652 O
developed 5398 5407 5653 5662 O
acute 5408 5413 5663 5668 O
renal 5414 5419 5669 5674 O
failure 5420 5427 5675 5682 O
with 5428 5432 5683 5687 O
a 5433 5434 5688 5689 O
peak 5435 5439 5690 5694 O
creatinine 5440 5450 5695 5705 O
of 5451 5453 5706 5708 O
3.0 5454 5457 5709 5712 O
with 5458 5462 5713 5717 O
associated 5463 5473 5718 5728 O
oliguria 5474 5482 5729 5737 O
. 5482 5483 5738 5739 O

He 5485 5487 5740 5742 O
developed 5488 5497 5743 5752 O
metabolic 5498 5507 5753 5762 B-Reason
acidosis 5508 5516 5763 5771 I-Reason
with 5517 5521 5772 5776 O
a 5522 5523 5777 5778 O
minimum 5524 5531 5779 5786 O
bicarb 5532 5538 5787 5793 O
of 5539 5541 5794 5796 O
18 5542 5544 5797 5799 O
, 5544 5545 5800 5801 O
improved 5546 5554 5802 5810 O
with 5555 5559 5811 5815 O
bicarbonate 5560 5571 5816 5827 B-Drug
boluses 5572 5579 5828 5835 B-Dosage
. 5579 5580 5836 5837 O

Electrolytes 5581 5593 5838 5850 O
were 5594 5598 5851 5855 O
monitored 5599 5608 5856 5865 O
and 5609 5612 5866 5869 O
repleted 5613 5621 5870 5878 O
per 5622 5625 5879 5882 O
protocol 5626 5634 5883 5891 O
. 5634 5635 5892 5893 O

Strict 5636 5642 5894 5900 O
I 5643 5644 5901 5902 O
& 5645 5646 5903 5904 O
Os 5647 5649 5905 5907 O
and 5650 5653 5908 5911 O
serum 5654 5659 5912 5917 O
chemistries 5660 5671 5918 5929 O
were 5672 5676 5930 5934 O
maintained 5677 5687 5935 5945 O
. 5687 5688 5946 5947 O

IV 5690 5692 5948 5950 B-Route
fluids 5693 5699 5951 5957 B-Drug
were 5700 5704 5958 5962 O
continued 5705 5714 5963 5972 O
given 5715 5720 5973 5978 O
acute 5721 5726 5979 5984 O
renal 5727 5732 5985 5990 O
failure 5733 5740 5991 5998 O
. 5740 5741 5999 6000 O

During 5743 5749 6001 6007 O
this 5750 5754 6008 6012 O
week 5755 5759 6013 6017 O
he 5760 5762 6018 6020 O
had 5763 5766 6021 6024 O
mild 5767 5771 6025 6029 O
ST 5772 5774 6030 6032 O
elevation 5775 5784 6033 6042 O
to 5785 5787 6043 6045 O
54 5788 5790 6046 6048 O
, 5790 5791 6049 6050 O
which 5792 5797 6051 6056 O
improved 5798 5806 6057 6065 O
prior 5807 5812 6066 6071 O
to 5813 5815 6072 6074 O
discharge 5816 5825 6075 6084 O
. 5825 5826 6085 6086 O

He 5828 5830 6087 6089 O
had 5831 5834 6090 6093 O
no 5835 5837 6094 6096 O
hyperbilirubinemia 5838 5856 6097 6115 O
, 5856 5857 6116 6117 O
myocarditis 5858 5869 6118 6129 O
or 5870 5872 6130 6132 O
coagulopathy 5873 5885 6133 6145 O
noted 5886 5891 6146 6151 O
. 5891 5892 6152 6153 O

He 5894 5896 6154 6156 O
was 5897 5900 6157 6160 O
thrombocytopenic 5901 5917 6161 6177 O
to 5918 5920 6178 6180 O
a 5921 5922 6181 6182 O
platelet 5923 5931 6183 6191 O
count 5932 5937 6192 6197 O
low 5938 5941 6198 6201 O
of 5942 5944 6202 6204 O
68 5945 5947 6205 6207 O
, 5947 5948 6208 6209 O
000 5948 5951 6210 6213 O
without 5952 5959 6214 6221 O
evidence 5960 5968 6222 6230 O
of 5969 5971 6231 6233 O
bleeding 5972 5980 6234 6242 O
. 5980 5981 6243 6244 O

He 5983 5985 6245 6247 O
was 5986 5989 6248 6251 O
anemic 5990 5996 6252 6258 O
and 5997 6000 6259 6262 O
was 6001 6004 6263 6266 O
transfused 6005 6015 6267 6277 O
with 6016 6020 6278 6282 O
packed 6021 6027 6283 6289 O
red 6028 6031 6290 6293 O
blood 6032 6037 6294 6299 O
cells 6038 6043 6300 6305 O
with 6044 6048 6306 6310 O
discharge 6049 6058 6311 6320 O
hemoglobin 6059 6069 6321 6331 O
of 6070 6072 6332 6334 O
9.1 6073 6076 6335 6338 O
. 6076 6077 6339 6340 O

By 6079 6081 6341 6343 O
[ 6082 6083 6344 6345 O
* 6083 6084 6346 6347 O
* 6084 6085 6348 6349 O
2178 6085 6089 6350 6354 O
- 6089 6090 6355 6356 O
2 6090 6091 6357 6358 O
- 6091 6092 6359 6360 O
7 6092 6093 6361 6362 O
* 6093 6094 6363 6364 O
* 6094 6095 6365 6366 O
] 6095 6096 6367 6368 O
he 6097 6099 6369 6371 O
had 6100 6103 6372 6375 O
recovered 6104 6113 6376 6385 O
from 6114 6118 6386 6390 O
side 6119 6123 6391 6395 O
effects 6124 6131 6396 6403 O
to 6132 6134 6404 6406 O
allow 6135 6140 6407 6412 O
for 6141 6144 6413 6416 O
discharge 6145 6154 6417 6426 O
to 6155 6157 6427 6429 O
home 6158 6162 6430 6434 O
. 6162 6163 6435 6436 O

CONDITION 6165 6174 6437 6446 O
ON 6175 6177 6447 6449 O
DISCHARGE 6178 6187 6450 6459 O
: 6187 6188 6460 6461 O
Alert 6190 6195 6462 6467 O
, 6195 6196 6468 6469 O
oriented 6197 6205 6470 6478 O
and 6206 6209 6479 6482 O
ambulatory 6210 6220 6483 6493 O
. 6220 6221 6494 6495 O

DISCHARGE 6223 6232 6496 6505 O
STATUS 6233 6239 6506 6512 O
: 6239 6240 6513 6514 O
To 6242 6244 6515 6517 O
home 6245 6249 6518 6522 O
with 6250 6254 6523 6527 O
his 6255 6258 6528 6531 O
family 6259 6265 6532 6538 O
. 6265 6266 6539 6540 O

DISCHARGE 6268 6277 6541 6550 O
DIAGNOSES 6278 6287 6551 6560 O
: 6287 6288 6561 6562 O

1 6289 6290 6563 6564 O
. 6290 6291 6565 6566 O
Metastatic 6292 6302 6567 6577 B-Reason
melanoma 6303 6311 6578 6586 I-Reason
status 6312 6318 6587 6593 O
post 6319 6323 6594 6598 O
cycle 6324 6329 6599 6604 O
1 6330 6331 6605 6606 O
, 6331 6332 6607 6608 O
week 6333 6337 6609 6613 O
1 6338 6339 6614 6615 O
, 6339 6340 6616 6617 O
high 6341 6345 6618 6622 B-Dosage
- 6345 6346 6623 6624 I-Dosage
dose 6351 6355 6625 6629 I-Dosage
IL 6356 6358 6630 6632 B-Drug
- 6358 6359 6633 6634 I-Drug
2 6359 6360 6635 6636 I-Drug
therapy 6361 6368 6637 6644 O
complicated 6369 6380 6645 6656 O
by 6381 6383 6657 6659 O
pulmonary 6384 6393 6660 6669 B-ADE
edema 6394 6399 6670 6675 I-ADE
, 6399 6400 6676 6677 O
and 6401 6404 6678 6681 O
bilateral 6409 6418 6682 6691 B-ADE
pleural 6419 6426 6692 6699 I-ADE
effusions 6427 6436 6700 6709 I-ADE
from 6437 6441 6710 6714 O
IL 6442 6444 6715 6717 B-Drug
- 6444 6445 6718 6719 I-Drug
2 6445 6446 6720 6721 I-Drug
induced 6447 6454 6722 6729 O
capillary 6455 6464 6730 6739 B-ADE
leak 6469 6473 6740 6744 I-ADE
, 6473 6474 6745 6746 O
with 6475 6479 6747 6751 O
respiratory 6480 6491 6752 6763 B-ADE
distress 6492 6500 6764 6772 I-ADE
. 6500 6501 6773 6774 O

2 6502 6503 6775 6776 O
. 6503 6504 6777 6778 O
Acute 6505 6510 6779 6784 B-ADE
renal 6511 6516 6785 6790 I-ADE
failure 6517 6524 6791 6798 I-ADE
related 6525 6532 6799 6806 O
to 6533 6535 6807 6809 O
IL 6536 6538 6810 6812 B-Drug
- 6538 6539 6813 6814 I-Drug
2 6539 6540 6815 6816 I-Drug
therapy 6541 6548 6817 6824 O
. 6548 6549 6825 6826 O

DISCHARGE 6551 6560 6827 6836 O
MEDICATIONS 6561 6572 6837 6848 O
: 6572 6573 6849 6850 O
Enalapril 6575 6584 6851 6860 B-Drug
20 6585 6587 6861 6863 B-Strength
mg 6588 6590 6864 6866 I-Strength
p.o. 6591 6595 6867 6871 B-Route
daily 6596 6601 6872 6877 B-Frequency
, 6601 6602 6878 6879 O
Lasix 6603 6608 6880 6885 B-Drug
20 6609 6611 6886 6888 B-Strength
mg 6612 6614 6889 6891 I-Strength
p.o. 6615 6619 6892 6896 B-Route
daily 6620 6625 6897 6902 B-Frequency
, 6625 6626 6903 6904 O
lorazepam 6627 6636 6905 6914 B-Drug
0.5 6637 6640 6915 6918 B-Strength
mg 6641 6643 6919 6921 I-Strength
q 6644 6645 6922 6923 B-Frequency
. 6645 6646 6924 6925 I-Frequency
6 6647 6648 6926 6927 I-Frequency
hours 6649 6654 6928 6933 I-Frequency
p.r.n. 6655 6661 6934 6940 I-Frequency
nausea 6662 6668 6941 6947 B-Reason
, 6668 6669 6948 6949 O
pravastatin 6670 6681 6950 6961 B-Drug
20 6682 6684 6962 6964 B-Strength
mg 6685 6687 6965 6967 I-Strength
p.o. 6688 6692 6968 6972 B-Route
daily 6693 6698 6973 6978 B-Frequency
, 6698 6699 6979 6980 O
Compazine 6700 6709 6981 6990 B-Drug
5 6710 6711 6991 6992 B-Strength
to 6712 6714 6993 6995 I-Strength
10 6715 6717 6996 6998 I-Strength
mg 6718 6720 6999 7001 I-Strength
q 6721 6722 7002 7003 B-Frequency
. 6722 6723 7004 7005 I-Frequency
i 6723 6724 7006 7007 I-Frequency
. 6724 6725 7008 7009 I-Frequency
d 6725 6726 7010 7011 I-Frequency
. 6726 6727 7012 7013 I-Frequency

p.r.n. 6728 6734 7014 7020 I-Frequency
nausea 6735 6741 7021 7027 B-Reason
. 6741 6742 7028 7029 O

FOLLOW 6744 6750 7030 7036 O
- 6750 6751 7037 7038 O
UP 6751 6753 7039 7041 O
PLANS 6754 6759 7042 7047 O
: 6759 6760 7048 7049 O
The 6762 6765 7050 7053 O
patient 6766 6773 7054 7061 O
will 6774 6778 7062 7066 O
return 6779 6785 7067 7073 O
to 6786 6788 7074 7076 O
clinic 6789 6795 7077 7083 O
on 6796 6798 7084 7086 O
[ 6799 6800 7087 7088 O
* 6800 6801 7089 7090 O
* 6801 6802 7091 7092 O
2178 6802 6806 7093 7097 O
- 6806 6807 7098 7099 O
2 6807 6808 7100 7101 O
- 6808 6809 7102 7103 O
10 6809 6811 7104 7106 O
* 6811 6812 7107 7108 O
* 6812 6813 7109 7110 O
] 6813 6814 7111 7112 O
for 6815 6818 7113 7116 O
assessment 6819 6829 7117 7127 O
of 6830 6832 7128 7130 O
his 6833 6836 7131 7134 O
clinical 6837 6845 7135 7143 O
status 6846 6852 7144 7150 O
prior 6853 6858 7151 7156 O
to 6859 6861 7157 7159 O
consideration 6862 6875 7160 7173 O
for 6876 6879 7174 7177 O
treatment 6880 6889 7178 7187 O
with 6890 6894 7188 7192 O
week 6895 6899 7193 7197 O
# 6900 6901 7198 7199 O
2 6901 6902 7200 7201 O
of 6903 6905 7202 7204 O
therapy 6906 6913 7205 7212 O
. 6913 6914 7213 7214 O

I 6917 6918 7215 7216 O
have 6919 6923 7217 7221 O
reviewed 6924 6932 7222 7230 O
the 6933 6936 7231 7234 O
discharge 6937 6946 7235 7244 O
summary 6947 6954 7245 7252 O
and 6955 6958 7253 7256 O
agree 6959 6964 7257 7262 O
with 6965 6969 7263 7267 O
the 6970 6973 7268 7271 O
hospital 6974 6982 7272 7280 O
course 6983 6989 7281 7287 O
and 6990 6993 7288 7291 O
disposition 6994 7005 7292 7303 O
as 7006 7008 7304 7306 O
dictated 7009 7017 7307 7315 O
by 7018 7020 7316 7318 O
[ 7021 7022 7319 7320 O
* 7022 7023 7321 7322 O
* 7023 7024 7323 7324 O
First 7024 7029 7325 7330 O
Name 7030 7034 7331 7335 O
8 7034 7035 7336 7337 O
( 7036 7037 7338 7339 O
NamePattern 7037 7048 7340 7351 O
2 7048 7049 7352 7353 O
) 7049 7050 7354 7355 O
622 7051 7054 7356 7359 O
* 7054 7055 7361 7362 O
* 7055 7056 7363 7364 O
] 7056 7057 7365 7366 O
[ 7058 7059 7367 7368 O
* 7059 7060 7369 7370 O
* 7060 7061 7371 7372 O
Last 7061 7065 7373 7377 O
Name 7066 7070 7378 7382 O
( 7071 7072 7383 7384 O
NamePattern 7072 7083 7385 7396 O
1 7083 7084 7397 7398 O
) 7084 7085 7399 7400 O
17265 7086 7091 7401 7406 O
* 7091 7092 7407 7408 O
* 7092 7093 7409 7410 O
] 7093 7094 7411 7412 O
. 7094 7095 7413 7414 O

[ 7123 7124 7415 7416 O
* 7124 7125 7417 7418 O
* 7125 7126 7419 7420 O
First 7126 7131 7421 7426 O
Name 7132 7136 7427 7431 O
11 7136 7138 7432 7434 O
( 7139 7140 7435 7436 O
Name 7140 7144 7437 7441 O
Pattern 7145 7152 7442 7449 O
1 7152 7153 7450 7451 O
) 7153 7154 7452 7453 O
* 7155 7156 7454 7455 O
* 7156 7157 7456 7457 O
] 7157 7158 7458 7459 O
[ 7159 7160 7460 7461 O
* 7160 7161 7462 7463 O
* 7161 7162 7464 7465 O
Last 7162 7166 7466 7470 O
Name 7167 7171 7471 7475 O
( 7172 7173 7476 7477 O
NamePattern 7173 7184 7478 7489 O
1 7184 7185 7490 7491 O
) 7185 7186 7492 7493 O
* 7187 7188 7494 7495 O
* 7188 7189 7496 7497 O
] 7189 7190 7498 7499 O
, 7190 7191 7500 7501 O
MD 7192 7194 7502 7504 O
[ 7195 7196 7505 7506 O
* 7196 7197 7507 7508 O
* 7197 7198 7509 7510 O
MD 7198 7200 7511 7513 O
Number 7201 7207 7514 7520 O
( 7207 7208 7521 7522 O
2 7208 7209 7523 7524 O
) 7209 7210 7525 7526 O
66804 7211 7216 7527 7532 O
* 7216 7217 7533 7534 O
* 7217 7218 7535 7536 O
] 7218 7219 7537 7538 O
Dictated 7221 7229 7539 7547 O
By 7230 7232 7548 7550 O
: 7232 7233 7551 7552 O
[ 7233 7234 7553 7554 O
* 7234 7235 7555 7556 O
* 7235 7236 7557 7558 O
Last 7236 7240 7559 7563 O
Name 7241 7245 7564 7568 O
( 7246 7247 7569 7570 O
NamePattern 7247 7258 7571 7582 O
1 7258 7259 7583 7584 O
) 7259 7260 7585 7586 O
18853 7261 7266 7587 7592 O
* 7266 7267 7593 7594 O
* 7267 7268 7595 7596 O
] 7268 7269 7597 7598 O
MEDQUIST 7270 7278 7599 7607 O
36 7278 7280 7608 7610 O

D 7281 7282 7611 7612 O
: 7282 7283 7613 7614 O
[ 7285 7286 7615 7616 O
* 7286 7287 7617 7618 O
* 7287 7288 7619 7620 O
2178 7288 7292 7621 7625 O
- 7292 7293 7626 7627 O
2 7293 7294 7628 7629 O
- 7294 7295 7630 7631 O
24 7295 7297 7632 7634 O
* 7297 7298 7635 7636 O
* 7298 7299 7637 7638 O
] 7299 7300 7639 7640 O
12 7301 7303 7641 7643 O
: 7303 7304 7645 7646 O
32 7304 7306 7647 7649 O
: 7306 7307 7651 7652 O
55 7307 7309 7653 7655 O

T 7310 7311 7656 7657 O
: 7311 7312 7658 7659 O
[ 7314 7315 7660 7661 O
* 7315 7316 7662 7663 O
* 7316 7317 7664 7665 O
2178 7317 7321 7666 7670 O
- 7321 7322 7671 7672 O
2 7322 7323 7673 7674 O
- 7323 7324 7675 7676 O
25 7324 7326 7677 7679 O
* 7326 7327 7680 7681 O
* 7327 7328 7682 7683 O
] 7328 7329 7684 7685 O
15 7330 7332 7686 7688 O
: 7332 7333 7689 7690 O
33 7333 7335 7691 7693 O
: 7335 7336 7694 7695 O
12 7336 7338 7696 7698 O

Job 7339 7342 7699 7702 O
# 7342 7343 7703 7704 O
: 7343 7344 7705 7706 O
[ 7346 7347 7707 7708 O
* 7347 7348 7709 7710 O
* 7348 7349 7711 7712 O
Job 7349 7352 7713 7716 O
Number 7353 7359 7717 7723 O
87177 7360 7365 7724 7729 O
* 7365 7366 7730 7731 O
* 7366 7367 7732 7733 O
] 7367 7368 7734 7735 O
cc 7370 7372 7736 7738 O
: 7372 7373 7739 7740 O
[ 7373 7374 7741 7742 O
* 7374 7375 7743 7744 O
* 7375 7376 7745 7746 O
Numeric 7376 7383 7747 7754 O
Identifier 7384 7394 7755 7765 O
87178 7395 7400 7766 7771 O
* 7400 7401 7772 7773 O
* 7401 7402 7774 7775 O
] 7402 7403 7776 7777 O

